We are following recommendations from governments to ensure we can keep our labs running, produce medication and to safely continue clinical trials and patient reporting.
The Lundbeck supply chain remains intact, and we have not experienced any supply disruptions. We are continuously monitoring the situation, and we are committed to doing all we can to anticipate and mitigate any potential issues with the availability of our therapies.Keeping our employees safe and safeguarding our ability to deliver treatments to people living with brain diseases remains priority.
We are closely collaborating with authorities, patient groups and other relevant stakeholders in different countries around the world. We are doing our utmost to support our local communities in the form of donations of medication and personal protective equipment (PPE).
The Lundbeck Foundation is at the forefront of supporting science to be able to prevent, treat and ultimately stop COVID-19. We are proud to be a part of the Lundbeck Foundation family.